The global cosmetic implants market size was valued at USD 10.9 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 8.8% from 2023 to 2030. Cosmetic implants are used to improve a person's appearance and correct anomalies brought on by inherited diseases, trauma, and accidents. Cosmetic implants made it easier for patients to repair damaged body components. After any incident, patients can more easily recoup or enhance their appearances. Cosmetic implants include face augmentation, soft tissue or injectable implants, hair grafts / implants, chest augmentation, buttock enhancement, and calf augmentation.
The COVID-19 epidemic presented major challenges for the health care industry. Since the majority of these treatments were determined to be non-urgent, all elective and cosmetic procedures were delayed or restricted throughout the COVID-19 pandemic to lower the chance of viral transmission. Throughout the COVID-19 epidemic, fewer aesthetic operations were carried out globally. For instance, approximately 24,529,875 cosmetic treatments were carried out in 2020, as compared to 24,982,304 in 2019, as per the International Society of Aesthetic Plastic Surgery's 2021 report. The fear of infection and the allocation of medical materials to COVID-19 management were the main causes of the decrease in procedures conducted. However, as COVID-19 cases decrease, the market is progressively stabilizing and cosmetic surgery demand is returning to normal levels.
The main drivers of the growth of the cosmetic implant market throughout the forecast period include rising demand for cosmetic implants, the emergence of new and innovative technologies, and rising awareness of aesthetic appearance. For instance, the annual Aesthetic Plastic Surgery Statistics published by the Aesthetic Society in April 2022 revealed that 148,000 women had their implants modified. The number of breast implant surgeries documented in England was 11,735 from January to December 2021, according to the Breast & Cosmetic Implant Registry, of which 2,375 involved reconstruction, 3080 replacement, and 25 involved relocation. Because of this, the market expansion is anticipated to be aided by the large number of implant processes being conducted globally.
Additionally, the market for cosmetic implants is expanding as a result of technological developments. The rise of the cosmetic implants market is driven by an increase in US Food & Drug Administration (FDA) approval in the cosmetic implants market. For instance, in May 2016, the U.S. Food & Drug Administration (FDA) approved Allergan’s, NATRELLE INSPIRA, a cohesive breast implants. These implants offer women undergoing reconstruction, augmentation or revision surgery a new breast shaping option that combines a high gel fill ratio and Allergan's highly cohesive gel for a customized result. Furthermore, rising demand for surgical cosmetic implants to enhance facial beauty and appearance fuels the development of global market.
The dental implants segment held 42.71% of the global market share in 2022, accounting for the largest proportion of the market. This can be due to the expanding therapeutic uses for dental implants as well as the rising need for prostheses. Another important aspect influencing the need for dental implants is the rise in traumatic dental injuries (TDIs). According to a March 2021 Scientific World Journal article, 25% of all school-aged children and teenagers between the ages of 7 and 19 experience a TDI that affects their permanent teeth. TDIs are experienced by 6.1% to 41.6% of people during their childhood or adolescence. Consequently, there is a high need for dental implants.
Additionally, a number of organizations are consistently attempting to introduce and develop advanced dental implants, which is another factor promoting market expansion. For instance, ZimVie Inc. introduced the T3 PRO Tapered Implant with Encoded Emergence Healing Abutment in the U.S. in June 2022 after getting clearance from the Food and Drug Administration. Therefore, it is anticipated that the dental implant market will expand significantly as a result of the aforementioned factors.
The polymers segment held 43.01% of the global market share in 2022, accounting for the largest proportion of the market, due to the rising need for procedures to rectify deformities. Polymeric materials are ideal for cosmetic implants since they have high tensile strength. In addition, additional advantages like flexibility, rigid support, and biocompatibility are projected to boost market expansion. Solid silicone implants used in augmentation surgery are the most widely utilized implants.
The biological material segment is predicted to have the highest CAGR during the projection period due to its closer resemblance to bodily tissues, which allows for simple adoption and benefits of biological cosmetic implants over synthetic ones. Additionally, rising R&D expenditures for the production of biocompatible implants are anticipated to fuel market expansion in the coming years.
North America dominated the market with revenue share of 35.6% in 2022. This is attributed to factors like the rising demand for cosmetic procedures, the expansion of awareness campaigns run by qualified dermatology specialists, and the nation's highest level of reimbursement. According to the annual Aesthetic Plastic Surgery Statistics published by the Aesthetic Society in April 2022, surgical operations reached in the US by 54% while non-surgical procedures increased by 44%. In 2021, an average cosmetic surgeon performed 320 surgical operations, with a 6% cost increase for surgical treatments and a 1% cost increase for non-surgical procedures. Additionally, it stated that women underwent 365,000 breast augmentations in 2021, making up almost 94% of all surgeries. As a result, the increasing number of surgeries carried out in the region is a significant element fueling the expansion of the cosmetic implants market during the period of the forecast year.
The market is anticipated to see the fastest growth rate is Asia Pacific over the forecast period. The Asia Pacific market is primarily driven by the region's huge untapped potential, economic growth, rising awareness among patients, and continuously developing healthcare infrastructure. In addition, during the forecast years, industry growth is anticipated to be driven by rising medical tourism initiatives supported by low procedure prices in China and India. Thus, propelling the market growth.
The continuous demand for cosmetic implants by multiple end-users has created numerous market opportunities for major players to capitalize on. For instance, in May 2023, BellaSeno GmbH, which is employing additive manufacturing technology to build resorbable scaffolds, published positive preliminary results from a pair of clinical studies of its resorbable breast & chest implants supported by its Australian affiliate, BellaSeno Pty. The findings were presented at the Royal Australasian College of Surgeons' (RACS) 91st Annual Scientific Congress in 2023. Some of the prominent players in the global cosmetic implants market include:
Dentsply Sirona Inc.
GC Aesthetics PLC.
Institut Straumann AG.
POLYTECH Health and Aesthetics GmbH
Zimmer Holdings Inc.
Market size value in 2023
USD 11.7 billion
Revenue forecast in 2030
USD 21.2 billion
CAGR of 8.8% from 2023 to 2030
Base year for estimation
2018 - 2021
2023 - 2030
Revenue in USD million and CAGR from 2023 to 2030
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Application, material, region
North America; Europe; Asia Pacific; Latin America; MEA
U.S.; Canada; Germany; UK; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; South Korea; Australia; Thailand; Brazil; Mexico, Argentina; South Africa; Saudi Arabia, UAE; Kuwait
Key companies profiled
3M; AbbVie, Inc; Danaher Corporation; Dentsply Sirona Inc.; GC Aesthetics PLC.; Institut Straumann AG.; POLYTECH Health and Aesthetics GmbH; Sientra Inc,; Zimmer Holdings Inc.; BellaSeno GmbH
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, grand view research has segmented the global cosmetic implants market report based on application, material, and region:
Application Outlook (Revenue, USD Million, 2018 - 2030)
Material Outlook (Revenue, USD Million, 2018 - 2030)
Regional Outlook (Revenue, USD Million, 2018 - 2030)
Middle East & Africa
b. The global cosmetic implants market size was estimated at USD 10.9 billion in 2022 and is expected to reach USD 11.7 billion in 2023.
b. The global cosmetic implants market is expected to grow at a compound annual growth rate of 8.8% from 2023 to 2030 to reach USD 21.2 billion by 2030.
b. North America dominated the cosmetic implants market with a share of 35.5% in 2022. This is attributable to presence of sophisticated healthcare infrastructure coupled with high awareness levels pertaining to physical and aesthetic appearances.
b. Some key players operating in the cosmetic implants market include Aesthetic and Reconstructive Technologies (AART) Inc., 3M Health Care, DENTSPLY International Inc., Allergan, Inc., GC Aesthetics, Implantech Associates Inc., Mentor Worldwide LLC, Institut Straumann AG, Sientra Inc., Nobel Biocare Holding AG, Zimmer Holdings Inc and Spectrum Designs Medical.
b. Key factors that are driving the market growth include the introduction of technological advancements such two form-stable silicone gel breast implants and growing expenditure levels among consumers pertinent to aesthetic procedures.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."